会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 2-substituted alkoxy-3-substituted-pyrazines
    • 2-取代的烷氧基-3-取代 - 吡嗪
    • US4894453A
    • 1990-01-16
    • US68228
    • 1987-06-30
    • Masao YasoYukio SuzukiKensuke ShibataDaisuke MochizukiEiichi Hayashi
    • Masao YasoYukio SuzukiKensuke ShibataDaisuke MochizukiEiichi Hayashi
    • C07D241/18C07D241/44
    • C07D241/44C07D241/18
    • A compound of the formula ##STR1## wherein Q is --CO-- or --CH.sub.2 --, R is hydroxyl, lower alkoxy, halogen, --NH-lower alkylene-OH, --NH-lower alkylene-arylthio, --NH-lower alkylene-halogen, ##STR2## in which ##STR3## is dilower alkylamino, cycloalkylamino, morpholino, ##STR4## in which R.sub.9 is hydrogen, lower alkyl or aryl, R.sub.10 is hydrogen, lower alkyl, hydroxy-lower alkyl, hydroxy-lower alkoxy-lower alkyl or di(aryl)-lower alkyl, m is an integer from 4 to 6, n is 2 or 3, R.sub.1 is alkyl or aryl-lower alkyl, R.sub.2 and R.sub.3 are each lower alkyl, or together form tetramethylene, and R.sub.4 is hydrogen, lower alkyl or aryl, in which aryl is phenyl which is optionally substituted with a group selected from the group consisting of 1-3 halogen, nitro, lower alkyl and lower alkoxy, or a pharmaceutically acceptable salt thereof, inhibits blood platelet aggregation, has vasodilating activity and inhibits lipoperoxide generation.
    • 其中Q为-CO-或-CH 2 - ,R为羟基,低级烷氧基,卤素,-NH-低级亚烷基-OH,-NH-低级亚烷基 - 芳硫基,-NH-低级亚烷基 - 卤素,其中是二元烷基氨基,环烷基氨基,吗啉代,其中R9是氢,低级烷基或芳基,R10是氢,低级烷基,羟基 - 低级 烷基,羟基 - 低级烷氧基 - 低级烷基或二(芳基) - 低级烷基,m为4-6的整数,n为2或3,R 1为烷基或芳基 - 低级烷基,R 2和R 3为低级烷基, 或一起形成四亚甲基,并且R 4是氢,低级烷基或芳基,其中芳基是苯基,其任选被选自1-3个卤素,硝基,低级烷基和低级烷氧基的基团取代,或药学上可接受的 其盐抑制血小板聚集,具有血管扩张活性并抑制脂肪过氧化物产生。
    • 10. 发明授权
    • 2-alkoxy-5,6,7,8-tetrahydroquinoxaline derivatives, and production
method and use thereof
    • 2-烷氧基-5,6,7,8-四氢喹喔啉衍生物及其制备方法和用途
    • US5578596A
    • 1996-11-26
    • US432168
    • 1995-05-08
    • Hideyuki WatanabeMasao YasoDaisuke Mochizuki
    • Hideyuki WatanabeMasao YasoDaisuke Mochizuki
    • C07D241/44C07D401/12C07D403/12A61K31/495A61K31/505
    • C07D401/12C07D241/44C07D403/12
    • Disclosed are a compound represented by formula (1) and a non-toxic salt thereof, a production method thereof, and a pharmaceutical composition for treating a serotonergic neuron-related disease comprising the same as an active ingredient: ##STR1## wherein R.sup.1 represents a hydrogen atom or a lower alkyl group; R.sup.2 represents a pyridyl group which is unsubstituted or substituted with 1 to 3 substituents each independently selected from the group consisting of a halogen atom, a lower alkyl group, a trifluoromethyl group, a lower alkoxy group, a carbamoyl group and a cyano group, or a pyrimidinyl group which is unsubstituted or substituted with 1 to 2 substituents each independently selected from the group consisting of a lower alkyl group and a lower alkoxy group; and n is an integer of from 2 to 5. Compound (1) of the present invention and a non-toxic salt thereof have a strong affinity for serotonin 1A receptor and, therefore, they are useful for preventing and treating serotonergic neuron-related diseases, such as motion sickness, space sickness, emesis, dizziness, depression, anxiety, eating disorder, and the like.
    • PCT No.PCT / JP93 / 01589第 371日期1995年5月8日 102(e)日期1995年5月8日PCT提交1993年11月4日PCT公布。 公开号WO94 / 11362 日期1994年5月25日公开是由式(1)表示的化合物及其无毒盐及其制备方法和用于治疗含有其作为活性成分的血清素能神经元相关疾病的药物组合物: (1)其中R1表示氢原子或低级烷基; R2表示未取代的或被1-3个独立地选自卤素原子,低级烷基,三氟甲基,低级烷氧基,氨基甲酰基和氰基的取代基取代的吡啶基,或 未取代或被1-2个独立地选自低级烷基和低级烷氧基的取代基取代的嘧啶基; 和n为2〜5的整数。本发明化合物(1)及其无毒盐对5-羟色胺1A受体具有强亲和力,因此可用于预防和治疗5-羟色胺能神经元相关疾病 ,如晕车,空间病,呕吐,眩晕,抑郁,焦虑,饮食失调等。